Back to Search Start Over

The mucosal adjuvant effect of plant polysaccharides for induction of protective immunity against Helicobacter pylori infection.

Authors :
Liu, Chang
Luo, Jiao
Xue, Ruo-Yi
Guo, Ling
Nie, Li
Li, Sun
Ji, Lu
Ma, Cong-Jia
Chen, Da-Qun
Miao, Kuan
Zou, Quan-Ming
Li, Hai-Bo
Source :
Vaccine. Feb2019, Vol. 37 Issue 8, p1053-1061. 9p.
Publication Year :
2019

Abstract

Abstract Some plant polysaccharides (PPSs) had been used as the adjuvants for systemic vaccination. In this study, we investigated whether PPSs could exhibit adjuvant effect at the mucosa. Groups of mice were intranasally immunized with Epimedium Polysaccharide (EPS), Trollius chinensis polysaccharide (TCPS), Siberian solomonseal rhizome polysaccharide (SSRPS) and Astragalus polysaccharides (APS) together with ovalbumin (OVA). Significantly higher levels of OVA-specific IgG in serum and secretory IgA in saliva, vaginal wash and intestinal lavage fluid were induced after immunization with OVA plus one of the four PPSs compared to OVA alone. Antigen absorption and TLR2 (Toll-like receptor 2) activation may be related to their mucosal adjuvant effect. Of note, when APS used as an adjuvant, intranasally vaccination with recombination UreB (rUreB, Urease subunit B) conferred more robust protection against Helicobacter pylori (H. pylori). Immunized with rUreB in combination APS resulted in mixed specific Th1 and Th17 immune response, which may contribute to the inhibition of H. pylori colonization. Though specific Th2-dominant responses were elicited when the other three PPS intranasally immunized with rUreB, no significant difference in the protective effect were found between those groups and rUreb alone group. Taken together, the four PPSs may be promising candidates for mucosal adjuvant, and APS could enhance rUreB-specific protective immunity against H. pylori infection. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0264410X
Volume :
37
Issue :
8
Database :
Academic Search Index
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
134422597
Full Text :
https://doi.org/10.1016/j.vaccine.2018.12.066